Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
+487K
-
Total reported value, excl. options
-
$18M
-
Value change
-
+$712K
-
Put/Call ratio
-
0.06
-
Number of buys
-
23
-
Number of sells
-
-22
-
Price
-
$1.53
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q1 2023
65 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q1 2023.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.13M shares), Tieton Capital Management, LLC (2.55M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (901K shares), GEODE CAPITAL MANAGEMENT, LLC (557K shares), MILLENNIUM MANAGEMENT LLC (513K shares), RENAISSANCE TECHNOLOGIES LLC (427K shares), GMT CAPITAL CORP (297K shares), CITADEL ADVISORS LLC (210K shares), and Cambridge Investment Research Advisors, Inc. (195K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.